Ondansetron Ranitidine Injection, 2 mg/ 1ml

Ondansetron (2mg) + Ranitidine (25mg) Injection is a combination formulation of Ondansetron, an antiemetic, and Ranitidine, an H2-receptor antagonist, designed to provide effective relief for nausea, vomiting, and gastric acid-related issues. Ondansetron works by blocking the action of serotonin, which is responsible for triggering nausea and vomiting, particularly after surgery or chemotherapy. Ranitidine helps in reducing the production of stomach acid, preventing conditions like acid reflux and ulcers. This combination is particularly useful for patients undergoing medical treatments such as chemotherapy, radiation, or post-operative recovery, where nausea and acid-related discomfort are common.

The synergy of Ondansetron and Ranitidine in Ranilair O Injection helps in controlling both nausea and gastric acid secretion, promoting patient comfort during critical recovery phases.